Ricerca adds to DMPK team
William DeMaio joins from Wyeth Research
DeMaio joins a team of bioanalytical and drug metabolism scientists that provides integrated pharmaceutical development services and analytical problem solving capabilities, offering support for Ricerca’s discovery and preclinical development programmes.
Prior to joining Ricerca, DeMaio was associate director of biotransformation at Wyeth Research (now Pfizer) in Collegeville, Pennsylvania, where he was responsible for drug metabolite identification and metabolism characterisation by mass spectrometry. He has expertise in chromatography, mass spectrometry, structural elucidation and drug development, as well as operating GLP-compliant bioanalytical and metabolism operations and training analysts in use of LC/MS equipment and data analysis.
